![Frank L. Porfido](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Frank L.
Porfido held the position of Chief Financial Officer at Tyme Technologies, Inc. in 2021 and Vice President-Finance at UroGen Pharma, Inc. from 2019 to 2021.
He earned an MBA from Fairleigh Dickinson University and an undergraduate degree from Pace University.
Anciens postes connus de Frank L. Porfido
| Sociétés | Poste | Fin |
|---|---|---|
| TYME TECHNOLOGIES, INC. | Directeur Financier/CFO | 16/09/2022 |
UroGen Pharma, Inc.
 UroGen Pharma, Inc. BiotechnologyHealth Technology Operates as a biotech company that developing and commercializing innovative solutions to treat urothelial and specialty cancers | Corporate Officer/Principal | 01/05/2021 |
Formation de Frank L. Porfido
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
6
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Tyme Technologies, Inc.
 Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops cancer metabolism-based therapeutics | Health Technology |
Fairleigh Dickinson University
 Fairleigh Dickinson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pace University
 Pace University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UroGen Pharma, Inc.
UroGen Pharma, Inc. BiotechnologyHealth Technology Operates as a biotech company that developing and commercializing innovative solutions to treat urothelial and specialty cancers | Health Technology |
